Wells Fargo & Company MN Boosts Holdings in Option Care Health, Inc. (NASDAQ:OPCH)

Wells Fargo & Company MN grew its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 9.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 180,391 shares of the company's stock after purchasing an additional 15,609 shares during the quarter. Wells Fargo & Company MN owned approximately 0.11% of Option Care Health worth $4,185,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in OPCH. Murphy & Mullick Capital Management Corp purchased a new stake in Option Care Health during the fourth quarter worth about $26,000. UMB Bank n.a. grew its position in shares of Option Care Health by 41.7% during the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock valued at $27,000 after acquiring an additional 346 shares during the period. Signaturefd LLC increased its stake in shares of Option Care Health by 487.9% during the 4th quarter. Signaturefd LLC now owns 1,211 shares of the company's stock worth $28,000 after purchasing an additional 1,005 shares during the last quarter. Blue Trust Inc. raised its holdings in shares of Option Care Health by 16.9% in the 4th quarter. Blue Trust Inc. now owns 4,703 shares of the company's stock worth $109,000 after purchasing an additional 681 shares during the period. Finally, Venturi Wealth Management LLC lifted its stake in Option Care Health by 2,621.3% in the fourth quarter. Venturi Wealth Management LLC now owns 4,735 shares of the company's stock valued at $110,000 after purchasing an additional 4,561 shares during the last quarter. 98.05% of the stock is currently owned by institutional investors.

Option Care Health Trading Up 1.9 %

Shares of Option Care Health stock traded up $0.62 during midday trading on Friday, reaching $32.80. 741,167 shares of the company's stock traded hands, compared to its average volume of 1,775,510. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The stock has a 50 day moving average of $33.34 and a 200-day moving average of $28.73. The company has a market cap of $5.39 billion, a PE ratio of 27.50, a price-to-earnings-growth ratio of 2.30 and a beta of 1.07. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $35.53.

Insiders Place Their Bets

In related news, insider Michael Bavaro sold 30,996 shares of the stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the transaction, the insider now directly owns 44,974 shares in the company, valued at $1,495,835.24. This trade represents a 40.80 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 0.64% of the company's stock.

Analyst Ratings Changes

Several analysts have recently issued reports on the stock. Barrington Research reissued an "outperform" rating and issued a $38.00 price target on shares of Option Care Health in a research report on Monday. JMP Securities reiterated a "market outperform" rating and issued a $36.00 price target on shares of Option Care Health in a research report on Tuesday. Bank of America upgraded Option Care Health from a "neutral" rating to a "buy" rating and raised their target price for the stock from $26.00 to $33.00 in a research note on Monday, January 13th. Jefferies Financial Group raised shares of Option Care Health from a "hold" rating to a "buy" rating and increased their price target for the stock from $26.00 to $35.00 in a report on Thursday, January 23rd. Finally, JPMorgan Chase & Co. upped their target price on shares of Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a report on Thursday, March 6th. Two equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $33.75.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.